DexCom Stock Forecast - Triple Exponential Smoothing

DXCM Stock  USD 74.46  0.78  1.04%   
The Triple Exponential Smoothing forecasted value of DexCom Inc on the next trading day is expected to be 74.61 with a mean absolute deviation of 1.05 and the sum of the absolute errors of 61.93. DexCom Stock Forecast is based on your current time horizon. Although DexCom's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of DexCom's systematic risk associated with finding meaningful patterns of DexCom fundamentals over time.
  
As of the 22nd of November 2024, Fixed Asset Turnover is likely to grow to 3.41, while Inventory Turnover is likely to drop 2.26. . As of the 22nd of November 2024, Net Income Applicable To Common Shares is likely to grow to about 412 M, while Common Stock Shares Outstanding is likely to drop about 246.4 M.
Triple exponential smoothing for DexCom - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When DexCom prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in DexCom price movement. However, neither of these exponential smoothing models address any seasonality of DexCom Inc.

DexCom Triple Exponential Smoothing Price Forecast For the 23rd of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of DexCom Inc on the next trading day is expected to be 74.61 with a mean absolute deviation of 1.05, mean absolute percentage error of 1.85, and the sum of the absolute errors of 61.93.
Please note that although there have been many attempts to predict DexCom Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that DexCom's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

DexCom Stock Forecast Pattern

Backtest DexComDexCom Price PredictionBuy or Sell Advice 

DexCom Forecasted Value

In the context of forecasting DexCom's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. DexCom's downside and upside margins for the forecasting period are 72.67 and 76.55, respectively. We have considered DexCom's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
74.46
74.61
Expected Value
76.55
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of DexCom stock data series using in forecasting. Note that when a statistical model is used to represent DexCom stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.2152
MADMean absolute deviation1.0497
MAPEMean absolute percentage error0.0148
SAESum of the absolute errors61.9346
As with simple exponential smoothing, in triple exponential smoothing models past DexCom observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older DexCom Inc observations.

Predictive Modules for DexCom

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DexCom Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
72.5274.4676.40
Details
Intrinsic
Valuation
LowRealHigh
59.1461.0881.91
Details
Bollinger
Band Projection (param)
LowMiddleHigh
67.8472.5077.16
Details
25 Analysts
Consensus
LowTargetHigh
124.67137.00152.07
Details

Other Forecasting Options for DexCom

For every potential investor in DexCom, whether a beginner or expert, DexCom's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. DexCom Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in DexCom. Basic forecasting techniques help filter out the noise by identifying DexCom's price trends.

DexCom Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DexCom stock to make a market-neutral strategy. Peer analysis of DexCom could also be used in its relative valuation, which is a method of valuing DexCom by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

DexCom Inc Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of DexCom's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of DexCom's current price.

DexCom Market Strength Events

Market strength indicators help investors to evaluate how DexCom stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DexCom shares will generate the highest return on investment. By undertsting and applying DexCom stock market strength indicators, traders can identify DexCom Inc entry and exit signals to maximize returns.

DexCom Risk Indicators

The analysis of DexCom's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in DexCom's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dexcom stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of DexCom to cross-verify your projections.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.157
Earnings Share
1.65
Revenue Per Share
10.089
Quarterly Revenue Growth
0.02
Return On Assets
0.0606
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.